NFKB1 and cancer: ROS trigger many signaling pathways in cancer cells to affect cell growth, differentiation, protein synthesis, glucose metabolism and survival pathways including MAPK/ERK, PI3K/Akt and IKK/NF-κB signaling pathways [42,43].